Latest The Million Women Study Stories
Relizen Honored as Top Women’s Health Consumer Packaged Goods Product at 2014 Editor’s Choice Awards New York (PRWEB) November 06, 2014 Relizen®,
Volpara Highlights Study that Shows Fully-Automated Volumetric Methods are Valid Alternatives to Measure Mammographic Breast Density and Predict Breast Cancer Risk Wellington,
Researchers: Automated Measurement of Volumetric Mammographic Density is a Promising Tool for Widespread Breast Cancer Risk Assessment WELLINGTON, New Zealand, July 28, 2014 /PRNewswire/
Unequal access to diagnosis and treatment results in deaths of 1,710 black women annually NEW YORK, March 4, 2014 /PRNewswire-USNewswire/ -- A national study published today found a black:
Hormone replacement therapy (HRT) taken regularly for six months after a knee or hip replacement seems to cut the risk of repeat surgery by around 40%.
Breast cancer risk associated with use of hormone replacement therapy (HRT) among postmenopausal women was variable when analyzed by race/ethnicity, body mass index (BMI), and breast density.
Hormone replacement therapy (HRT) significantly improves muscle function – down to the muscle fiber level – in postmenopausal women.
According to a study published in the journal BMJ, taking hormone replacement therapy (HRT) may reduce the risk of developing heart problems.
HRT therapy has been subject to much discussion due to both positive effects (reduced risk of cardiovascular disease) and negative effects (increased risk of breast cancer).
- totally perplexed and mixed up.